FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049891831> ?p ?o ?g. }

• W2049891831 endingPage "169" @default.
• W2049891831 startingPage "163" @default.
• W2049891831 abstract "Melanoma therapy has recently seen significant progress, with several new drugs in phase II/III trials showing promising results. In this review, we discuss the most promising immunotherapies either already established or being developed, concentrating on agents for which there are high-level data to support or refute their role in treating this disease. This topic is timely, given the lengthy list of immune checkpoint inhibitors and vaccine formulations in development for melanoma.The discovery of immune checkpoint proteins like CTLA-4, PD-1 and CD40 and the development of antibodies and small molecules that either inhibit or promote their activity has lent a huge impetus to the immunotherapy of melanoma. The development of vaccines that include agonists of various immune signaling like the MAGE-3 ASCI has also revived the field of cancer vaccines. Melanoma is the 'poster child' for immunotherapy of cancer, since a recent randomized phase III trial showed a survival benefit for immunotherapy.The burgeoning field of immunotherapy for melanoma has important implications for clinicians, and for the novel paradigms of treatment and response assessment that immunotherapies will promote. The unique side-effect profile for immune checkpoint inhibitors will be a challenge but new skills for dealing with them in community based practice will be learned. The concept that physicians might see late regression, or progression followed by regression will cause a sea-change in the way patients are treated, since treating beyond progression may be suitable in some cases using immunotherapy." @default.
• W2049891831 created "2016-06-24" @default.
• W2049891831 creator A5047177507 @default.
• W2049891831 date "2011-03-01" @default.
• W2049891831 modified "2023-09-23" @default.
• W2049891831 title "Immunotherapy for melanoma" @default.
• W2049891831 cites W1483682701 @default.
• W2049891831 cites W1493383266 @default.
• W2049891831 cites W1525262466 @default.
• W2049891831 cites W1761214387 @default.
• W2049891831 cites W1767113662 @default.
• W2049891831 cites W1828940258 @default.
• W2049891831 cites W1908752382 @default.
• W2049891831 cites W1937682064 @default.
• W2049891831 cites W1950572133 @default.
• W2049891831 cites W1977917700 @default.
• W2049891831 cites W1990435553 @default.
• W2049891831 cites W1991287153 @default.
• W2049891831 cites W1995012480 @default.
• W2049891831 cites W2010121426 @default.
• W2049891831 cites W2016789384 @default.
• W2049891831 cites W2017251888 @default.
• W2049891831 cites W2028376975 @default.
• W2049891831 cites W2029086221 @default.
• W2049891831 cites W2034359690 @default.
• W2049891831 cites W2034745242 @default.
• W2049891831 cites W2041365671 @default.
• W2049891831 cites W2042939784 @default.
• W2049891831 cites W2047127667 @default.
• W2049891831 cites W2048896826 @default.
• W2049891831 cites W2058899594 @default.
• W2049891831 cites W2063264144 @default.
• W2049891831 cites W2064932721 @default.
• W2049891831 cites W2065367621 @default.
• W2049891831 cites W2078197336 @default.
• W2049891831 cites W2081509224 @default.
• W2049891831 cites W2085687864 @default.
• W2049891831 cites W2089758672 @default.
• W2049891831 cites W2095826876 @default.
• W2049891831 cites W2096158777 @default.
• W2049891831 cites W2097995306 @default.
• W2049891831 cites W2099289479 @default.
• W2049891831 cites W2099486531 @default.
• W2049891831 cites W2100158834 @default.
• W2049891831 cites W2103767560 @default.
• W2049891831 cites W2104732141 @default.
• W2049891831 cites W2105998729 @default.
• W2049891831 cites W2107321795 @default.
• W2049891831 cites W2109465910 @default.
• W2049891831 cites W2109490990 @default.
• W2049891831 cites W2110218114 @default.
• W2049891831 cites W2112601576 @default.
• W2049891831 cites W2112853593 @default.
• W2049891831 cites W2115278843 @default.
• W2049891831 cites W2116169737 @default.
• W2049891831 cites W2118449798 @default.
• W2049891831 cites W2118471749 @default.
• W2049891831 cites W2119198740 @default.
• W2049891831 cites W2121315503 @default.
• W2049891831 cites W2123900004 @default.
• W2049891831 cites W2124446900 @default.
• W2049891831 cites W2127734125 @default.
• W2049891831 cites W2129806226 @default.
• W2049891831 cites W2129888937 @default.
• W2049891831 cites W2136313650 @default.
• W2049891831 cites W2137993599 @default.
• W2049891831 cites W2141745968 @default.
• W2049891831 cites W2148523692 @default.
• W2049891831 cites W2149244682 @default.
• W2049891831 cites W2151246207 @default.
• W2049891831 cites W2161550811 @default.
• W2049891831 cites W2161558877 @default.
• W2049891831 cites W2164918836 @default.
• W2049891831 cites W2167925208 @default.
• W2049891831 cites W2218762100 @default.
• W2049891831 cites W2256291785 @default.
• W2049891831 cites W2257968979 @default.
• W2049891831 cites W2281900984 @default.
• W2049891831 cites W2319534054 @default.
• W2049891831 cites W2326004572 @default.
• W2049891831 cites W2335365056 @default.
• W2049891831 cites W2338699203 @default.
• W2049891831 cites W4230274068 @default.
• W2049891831 cites W4256189622 @default.
• W2049891831 doi "https://doi.org/10.1097/cco.0b013e3283436e79" @default.
• W2049891831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21192262" @default.
• W2049891831 hasPublicationYear "2011" @default.
• W2049891831 type Work @default.
• W2049891831 sameAs 2049891831 @default.
• W2049891831 citedByCount "37" @default.
• W2049891831 countsByYear W20498918312012 @default.
• W2049891831 countsByYear W20498918312013 @default.
• W2049891831 countsByYear W20498918312014 @default.
• W2049891831 countsByYear W20498918312015 @default.
• W2049891831 countsByYear W20498918312017 @default.
• W2049891831 countsByYear W20498918312019 @default.
• W2049891831 countsByYear W20498918312020 @default.
• W2049891831 countsByYear W20498918312021 @default.

• next